References
- Ferlay J , ErvikM , LamFet al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon, France (2020). (Accessed 21June2022). https://gco.iarc.fr/today
- National Cancer Institute. SEER Cancer Statistics Factsheets: Common Cancer Sites. MD, USA (Accessed 21June2022). https://seer.cancer.gov/statfacts/html/common.html
- National Cancer Institute. SEER Cancer Stat Facts: Bladder Cancer. MD, USA (Accessed 21June2022). https://seer.cancer.gov/statfacts/html/urinb.html
- Compérat E , LarréS , RoupretMet al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch.466(5), 589–594 (2015).
- Babjuk M , BurgerM , CompératEMet al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) – 2019 Update. Eur. Urol.76(5), 639–657 (2019).
- Lamm DL . Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin. Infect. Dis.31(Suppl. 3), S86–S90 (2000).
- US Food and Drug Association . BCG Live (for intravesical use) TICE® BCG (2009). MD, USA (Accessed 21June2022). www.fda.gov/media/76396/download
- American Urological Association . Intravesical administration of therapeutic medication for the treatment of bladder cancer (2020). MD, USA (Accessed 21June2022). www.auanet.org/guidelines/guidelines/intravesical-administration-of-therapeutic-medication
- Yip W , AshrafiA , DaneshmandS. High-grade T1 Urothelial carcinoma: where do we stand?Curr. Urol. Rep.20(12), 79 (2019).
- Palou J , SylvesterRJ , FabaORet al. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin. Eur. Urol.62(1), 118–125 (2012).
- Lawrence RM , LawrenceRA. Breast milk and infection. Clin. Perinatol.31(3), 501–528 (2004).
- Loveday M , HlanguS , FurinJ. Breastfeeding in women living with tuberculosis. Int. J. Tuberc. Lung Dis.24(9), 880–891 (2020).
- Adhikari M . Tuberculosis and tuberculosis/HIV co-infection in pregnancy. Semin. Fetal Neonatal Med.14(4), 234–240 (2009).